SCHEMBL25835385

SCHEMBL25835385

COc1ccccc1C1=CC(=O)[C@H](O)CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
ACHE P22303 1/20 0.41
POLL Q9UGP5 1/20 0.40
CREBBP Q92793 1/20 0.40
PTPRC P08575 1/20 0.40
PTPN1 P18031 1/20 0.40
PTGS2 P35354 1/20 0.40
CYP19A1 P11511 1/20 0.38
KDM4E B2RXH2 3/20 0.38
EDNRB P24530 1/20 0.37
EDNRA P25101 1/20 0.37
ERN1 O75460 1/20 0.37
PDE5A O76074 1/20 0.37
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
APP P05067 1/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
MAPT P10636 1/20 0.37
DUSP3 P51452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25835384 0.76 L3MBTL1 (0.44) L3MBTL1ACHEPTPRCPTPN1PTGS2
SCHEMBL25834709 0.76 L3MBTL1 (0.44) L3MBTL1ACHEPTPRCPTPN1PTGS2
SCHEMBL25834382 0.73 L3MBTL1 (0.43) L3MBTL1ACHECREBBPPTPRCPTPN1
SCHEMBL25836945 0.73 PTGS2 (0.35) POLLPTGS2KDM4EALDH1A1MAPT
SCHEMBL25835354 0.73 BACE1 (0.50) PTPN1KDM4EALDH1A1TDP1MEN1
SCHEMBL25835351 0.73 BACE1 (0.39) PTPRCPTPN1KDM4EALDH1A1MAPT
SCHEMBL25835356 0.71 HDAC4 (0.46) EDNRBEDNRAALDH1A1
SCHEMBL25604493 0.67 ACHE (0.68) ACHEPOLLCYP19A1KDM4EMEN1
SCHEMBL28483481 0.66 L3MBTL1 (0.50) L3MBTL1PTPRCPTPN1PTGS2KDM4E
SCHEMBL25834322 0.66 MAPT (0.53) L3MBTL1PTPRCPTPN1PTGS2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES NFE2L2, DUOX1, DUOX2 L3MBTL1 4202/4885ACHE 1283/4885POLL 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.